ARCHIVES

DCT’s Experimental Therapeutic Program Outlined to Board

This article is from The Cancer Letter archive.

Vol. 01 No. 18 | May 2, 1975

Download PDF Visit The Full Archive

Related Articles

Komen Deal With KFC Yields Buckets Of Discord

April 23, 2010

Funding Opportunities

November 2, 2002

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

ASCO Foundation Raised $200,000 In Its First Year.

June 2, 2000

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

December 15, 2000

Five New Members Appointed To The National Cancer Advisory Board

July 8, 2011